INS and obesity due to melanocortin 4 receptor deficiency: It has previously been shown in animal models that TRF has many beneficial effects, including a reduction in body mass, the prevention of obesity, an improvement in insulin sensitivity, a reduction in hepatic fat content, the prevention of hepatosteatosis and hyperlipidemia, and the amelioration of hepatic ischemia-reperfusion injury and inflammation4–8.